ArticleLeukemia & lymphoma2022

Durable response to ivosidenib in post-transplant relapse and leukemic transformation of myelodysplastic syndrome with new complex karyotype and

Hanan Alkhaldi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.